CANNON MICHAEL D
Reporting owner on Forms 3, 4 and 5, CIK 1203602.
CANNON MICHAEL D reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Moleculin Biotech, Inc. CIK 1659617 | director | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| MBRX · Moleculin Biotech, Inc.Stock Options (right to buy), derivative | 2026-11-17 | A granted | +4,000 | 4,334 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-037747 | Moleculin Biotech, Inc. | 2026-11-19 |